Revenue | ₹3.23Cr |
Net Profits | ₹0.16Cr |
Net Profit Margins | 4.95% |
Ishita Drugs & Industries Ltd’s revenue fell -23.1% since last year same period to ₹3.23Cr in the Q3 2025-2026. On a quarterly growth basis, Ishita Drugs & Industries Ltd has generated 2.87% jump in its revenue since last 3-months.
Ishita Drugs & Industries Ltd’s net profit fell -33.33% since last year same period to ₹0.16Cr in the Q3 2025-2026. On a quarterly growth basis, Ishita Drugs & Industries Ltd has generated 14.29% jump in its net profits since last 3-months.
Ishita Drugs & Industries Ltd’s net profit margin fell -13.31% since last year same period to 4.95% in the Q3 2025-2026. On a quarterly growth basis, Ishita Drugs & Industries Ltd has generated 11.1% jumped in its net profit margins since last 3-months.
The revenue for Ishita Drugs & Industries Ltd in the Q3 results 2025 was ₹3.23Cr.
The net profit for Ishita Drugs & Industries Ltd in the Q3 results 2025 was ₹0.16Cr.
The net profit margin for Ishita Drugs & Industries Ltd in the Q3 results 2025 was 4.95%.
The revenue for Ishita Drugs & Industries Ltd in the Q3 results 2024 was ₹4.20Cr.
The net profit for Ishita Drugs & Industries Ltd in the Q3 results 2024 was ₹0.24Cr.
The net profit margin for Ishita Drugs & Industries Ltd in the Q3 results 2024 was 5.71%.